| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022706 |
| Receipt No. | R000026164 |
| Official scientific title of the study | Usefulness of intraoperative nerve monitoring in predicting postoperative recurrent laryngeal nerve palsy in esophageal cancer surgery |
| Date of disclosure of the study information | 2016/06/12 |
| Last modified on | 2016/06/12 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Usefulness of intraoperative nerve monitoring in predicting postoperative recurrent laryngeal nerve palsy in esophageal cancer surgery | |
| Title of the study (Brief title) | Intraoperative recurrent laryngeal nerve monitoring | |
| Region |
|
|
| Condition | ||
| Condition | esophagealcancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To reveal the usefulness of intraoperative nerve monitoring in predicting postoperative recurrent laryngeal nerve palsy |
| Basic objectives2 | Others |
| Basic objectives -Others | To reveal the usefulness of intraoperative nerve monitoring in predicting the severity of postoperative recurrent laryngeal nerve palsy |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The relationship between the amplitude of electromyogram and the occurence of postoperative vocal cord palsy |
| Key secondary outcomes | The relationship between the amplitude of electromyogram and the occurence of persistent vocal cord palsy |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Use of intraoperative nerve monitor
The vagus and recurrent laryngeal nerves are stimulated with the current of 1mA for 3 seconds after lymph node dissection |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who undergo esophagectomy with 3 field lymph node dissection for esophageal cancer | |||
| Key exclusion criteria | Patients with preoperative recurrent laryngeal nerve palsy | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Yuichiro Doki |
| Organization | Osaka university |
| Division name | Surgery |
| Address | 2-2 Yamadaoka,Suitashi,Osaka |
| TEL | 0668793251 |
| ydoki@gesurg.med.osala-u.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Kanemura |
| Organization | Osaka university |
| Division name | Surgery |
| Address | 2-2 Yamadaoka,Suitashi,Osaka |
| TEL | 0668793251 |
| Homepage URL | |
| kanemura@tonbyo.org | |
| Sponsor | |
| Institute | Osaka university |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Osaka university |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026164 |